NEWS:

Press Release

For Immediate Release

5 December 2016

Think Tank urges action to improve uptake of Shingles Vaccine among older people

Responding to the news of falls in uptake of the shingles vaccination, the International Longevity Centre UK (ILC-UK) has urged a change to its eligibility guidelines.

Public Health England has reported a decline in the uptake of the Shingles vaccination in both the routine (70 year old) and catch up (78 years old) cohorts (from 61.8% in 2013/14 to 54.9% in 2015/16 and from 57.8% in 2014/15 to 55.5% in 2015/16, respectively).

In 2013, ILC-UK published “Immune Response”, calling for a lifecourse approach to immunisation and making 30 plus recommendations for policy action.

In 2015, ILC-UK launched a European Adult Immunisation Hub, which seeks to provide information and news about adult immunisation across Europe.

David Sinclair, Director, ILC-UK and Editor of the European Adult Immunisation Hub said:

“Vaccination is not just for kids. In an ageing society we need a much greater focus on improving awareness and uptake of vaccination among adults.

Anything we can do to reduce likelihood of pain is of huge importance in old age, with 6 in 10 people in their mid-70s suffering from pain.

Shingles can be a significant cause of pain in old age and vaccination is an effective way of reducing the likelihood that we will suffer from it. We must ensure that older people eligible for the Shingles vaccination take up their right to receive it.

Some parts of the country have very low coverage of the Shingles vaccine among eligible people. It is important that Public Health England and the Department of Health work to ensure that we don’t see emerging a postcode lottery in access to the vaccine.

The complexity of the age of eligibility guidelines for shingles will no doubt be hampering the ability to communicate uptake to relevant individuals. Perhaps now is the time to extend eligibility to everyone between 70 and 80, after all, all of these people are at risk and would benefit from vaccination.”

Details of who is eligible for a shingles vaccine are available here: http://www.nhs.uk/Conditions/vaccinations/Pages/who-can-have-the-shingles-vaccine.aspx

See the European Adult Immunisation Website for more information about the latest figures for Shingles uptake: http://www.adultimmunisation.eu/shinglesherpes-zoster/shingles-vaccination-uptake-falls-england/

Contact

David Eaton (davideaton@ilcuk.org.uk) 02073400440 or 07851042609

Notes

The International Longevity Centre – UK (ILC-UK) is a futures organisation focussed on some of the biggest challenges facing Government and society in the context of demographic change.


The European Adult Immunisation Hub is available at: http://www.adultimmunisation.eu/.

TOP STORIES

ILC-UK are once again looking for someone to speak for 10 minutes on the plenary platform in front of 250 people at our annual Future of Ageing Conference (29th November, London).

“Auto-enrolment has successfully led to millions more saving each month towards a pension, but the Committee is right to call for action to get people saving more. We are pleased they support our recommendations to consider automatic escalation of pension contributions for some individuals, and we agree that a strategy is needed to automatically-enrol the self-employed."

Dr Brian Beach, Senior Research Fellow at ILC-UK and who gave oral evidence to the Committee, welcomes the Committee’s call for stronger action by Government and EHRC and says it’s crucial that employers understand what ageism really is.

“The latest Fiscal Sustainability Report makes it very clear that we are facing an uncertain future. Demographic pressures are set to continue to dominate the agenda, with health, pension and adult social care spending all set to rise as a proportion of total GDP."

Are you looking for a short-term paid role in a think tank over the summer?
The independent think tank the International Longevity Centre – UK (ILC-UK) is seeking a summer intern to start on Monday 23 July. The intern would work 4 days a week for a period of 4 weeks, with the possibility of extension.

New research ‘An Economic Analysis of Flu Vaccination’ paints a picture of lives saved and costs averted, but more needs to be done to increase uptake

CATEGORIES: